ArticleEating and weight disorders : EWD2025
Trends, prevalence, incidence, and disability-adjusted life years of anorexia nervosa and bulimia nervosa in Iran: Global Burden of Disease Study.
Article in Eating and weight disorders : EWD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcranial Direct Current Stimulation in Anorexia Nervosa: A Randomized Sham-Controlled Trial.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesGiven the significant prevalence of mental health disorders in Iran, this research seeks to examine various epidemiological aspects related to eating disorders (ED). The study specifically focuses on key metrics, including prevalence, incidence, Disability-Adjusted Life Years (DALYs), Years Lived with Disability (YLDs), and Years of Life Lost (YLLs), within the Iranian population.
methodsThis research utilized data from the GBD 2019. Indicators related to disease burden, including prevalence, incidence, DALYs, YLDs, and YLLs, were extracted from the database. Population estimates and 95% uncertainty intervals (UIs) were calculated. All results are reported per 100,000 populations.
resultsThe age-standardized prevalence rate (ASPR) was documented at 254 per 100,000, with a uncertainty interval ranging from 189 to 328. The age-standardized disability-adjusted life years (DALYs) were calculated at 53.94 per 100,000, within an interval of 33.53 to 80.20. Likewise, the age-standardized years lived with disability (YLDs) were reported at 53.92 per 100,000, with a range extending from 33.51 to 53.92. In 2019, the Age-Standardized Prevalence Rate (ASPR) for anorexia nervosa (AN) was recorded at 68.47 per 100,000 individuals, while for bulimia nervosa (BN), it was 186.42 per 100,000. The ASPR for eating disorders (ED) overall stood at 190.4 per 100,000 for males and 320.33 per 100,000 for females in the same year.
conclusionAn analysis of the impact of eating disorders (ED) in Iran from 1990 to 2019 highlights a significant increase in their associated burden. This upward trend emphasizes the urgent necessity for the development and implementation of comprehensive health policies aimed at expanding access to mental health care services. Enhancing such access is vital, as it could substantially contribute to alleviating the burden of eating disorders by fostering more effective prevention and treatment strategies. LEVEL OF EVIDENCE: Level IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.